• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.左炔诺孕酮宫内缓释系统在妇科疾病中的临床应用。
Obstet Gynecol Sci. 2013 Mar;56(2):67-75. doi: 10.5468/OGS.2013.56.2.67. Epub 2013 Mar 12.
2
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.左炔诺孕酮释放激素系统（LNG-IUS）的非避孕用途——一项系统的调查与综述
Eur J Obstet Gynecol Reprod Biol. 2006 Mar 1;125(1):9-28. doi: 10.1016/j.ejogrb.2005.10.029. Epub 2005 Dec 1.
3
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2015 Apr 30(4):CD002126. doi: 10.1002/14651858.CD002126.pub3.
4
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.使用左炔诺孕酮宫内节育系统对严重增大的子宫腺肌病子宫进行药物治疗。
Contraception. 1999 Sep;60(3):173-5. doi: 10.1016/s0010-7824(99)00075-x.
5
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.用于治疗月经过多的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2005 Oct 19(4):CD002126. doi: 10.1002/14651858.CD002126.pub2.
6
Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.左炔诺孕酮宫内节育系统对一名肾移植患者子宫肌瘤的影响。
Contraception. 1999 Jul;60(1):51-3. doi: 10.1016/s0010-7824(99)00061-x.
7
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的风险效益评估。
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
8
Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.左炔诺孕酮宫内缓释系统和 T380A 宫内节育器对有和无子宫腺肌病妇女痛经和出血天数的影响。
Contraception. 2012 Nov;86(5):458-63. doi: 10.1016/j.contraception.2012.04.001. Epub 2012 Jul 24.
9
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2009 Oct 7(4):CD007245. doi: 10.1002/14651858.CD007245.pub2.
10
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.左炔诺孕酮宫内节育系统用于辅助他莫昔芬治疗的乳腺癌女性的子宫内膜保护
Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD007245. doi: 10.1002/14651858.CD007245.pub3.

引用本文的文献

1
GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol.基于 GnRH-a 的生育保存治疗不典型子宫内膜增生（AEH）和早期子宫内膜癌（EC）患者：一项多中心、开放标签、随机设计的临床试验方案。
Trials. 2024 Sep 2;25(1):578. doi: 10.1186/s13063-024-08414-0.
2
An age-period-cohort analysis of hysterectomy incidence trends in Germany from 2005 to 2019.2005 年至 2019 年德国子宫切除术发病率趋势的年龄-时期-队列分析。
Sci Rep. 2024 Jul 2;14(1):15110. doi: 10.1038/s41598-024-66019-8.
3
Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.非典型子宫内膜增生和子宫内膜癌患者的保留生育力方法：当前证据和未来方向。
Int J Mol Sci. 2022 Feb 25;23(5):2531. doi: 10.3390/ijms23052531.
4
Prediction of Myometrial Invasion in Stage I Endometrial Cancer by MRI: The Influence of Surgical Diagnostic Procedure.MRI对Ⅰ期子宫内膜癌肌层浸润的预测：手术诊断程序的影响
Cancers (Basel). 2021 Jun 30;13(13):3275. doi: 10.3390/cancers13133275.
5
Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.非典型子宫内膜增生和子宫内膜癌的保留生育功能治疗：Cochrane系统评价方案
Adv Ther. 2021 May;38(5):2717-2731. doi: 10.1007/s12325-021-01693-y. Epub 2021 Apr 8.
6
Laparoscopically assisted Adenomyomectomy Using the Double/Multiple-Flap Method with Temporary Occlusion of the Bilateral Uterine Artery and Utero-Ovarian Vessels in Comparison with the Double/Multiple-Flap Only Method.腹腔镜辅助腺肌病切除术：采用双侧子宫动脉和子宫卵巢血管临时阻断的双瓣/多瓣法与单纯双瓣/多瓣法的比较
Geburtshilfe Frauenheilkd. 2021 Mar;81(3):321-330. doi: 10.1055/a-1337-2690. Epub 2021 Mar 5.
7
Post hysteroscopic progesterone hormone therapy in the treatment of endometrial polyps.宫腔镜术后孕激素激素疗法治疗子宫内膜息肉
Pak J Med Sci. 2018 Sep-Oct;34(5):1267-1271. doi: 10.12669/pjms.345.15330.
8
Drug delivery for the treatment of endometriosis and uterine fibroids.用于治疗子宫内膜异位症和子宫肌瘤的药物输送。
Drug Deliv Transl Res. 2017 Dec;7(6):829-839. doi: 10.1007/s13346-017-0423-2.
9
Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management.孕激素宫内节育器与二甲双胍：子宫内膜增生和早期子宫内膜癌的医学管理
Healthcare (Basel). 2017 Jul 8;5(3):30. doi: 10.3390/healthcare5030030.
10
Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.在接受高剂量口服孕激素和左炔诺孕酮宫内节育系统治疗的早期子宫内膜癌患者中，刮宫术比子宫内膜抽吸活检更准确。
J Gynecol Oncol. 2017 Jan;28(1):e1. doi: 10.3802/jgo.2017.28.e1. Epub 2016 Aug 2.

本文引用的文献

1
Levonorgestrel intrauterine system--first-line therapy for heavy menstrual bleeding.左炔诺孕酮宫内节育系统——月经过多的一线治疗方法
N Engl J Med. 2013 Jan 10;368(2):184-5. doi: 10.1056/NEJMe1214191.
2
Levonorgestrel intrauterine system versus medical therapy for menorrhagia.左炔诺孕酮宫内节育系统与药物治疗月经过多的疗效比较。
N Engl J Med. 2013 Jan 10;368(2):128-37. doi: 10.1056/NEJMoa1204724.
3
Management of endometrial precancers.子宫内膜癌前病变的管理。
Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: 10.1097/aog.0b013e31826bb121.
4
Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009).醋酸甲羟孕酮联合左炔诺孕酮宫内缓释系统治疗年轻早期子宫内膜癌的单臂前瞻性多中心研究：韩国妇科肿瘤学组研究（KGOG2009）。
Jpn J Clin Oncol. 2012 Dec;42(12):1215-8. doi: 10.1093/jjco/hys171. Epub 2012 Oct 15.
5
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.保留生育功能治疗子宫内膜癌和非典型性复杂子宫内膜增生的复发、缓解和活产率：系统评价和荟萃分析。
Am J Obstet Gynecol. 2012 Oct;207(4):266.e1-12. doi: 10.1016/j.ajog.2012.08.011. Epub 2012 Aug 10.
6
Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.宫内节育系统用于治疗与子宫内膜异位症相关的盆腔疼痛：一项随机对照试验。
Obstet Gynecol. 2012 Mar;119(3):519-26. doi: 10.1097/AOG.0b013e31824264c3.
7
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).左炔诺孕酮宫内节育系统（LNG-IUS）的新适应证。
Acta Obstet Gynecol Scand. 2012 Jan;91(1):3-9. doi: 10.1111/j.1600-0412.2011.01303.x. Epub 2011 Nov 9.
8
Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma.左炔诺孕酮宫内节育系统治疗子宫肌瘤的疗效。
Int J Gynaecol Obstet. 2012 Jan;116(1):35-8. doi: 10.1016/j.ijgo.2011.07.031. Epub 2011 Sep 28.
9
Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study.醋酸甲羟孕酮联合左炔诺孕酮宫内节育系统治疗年轻早期子宫内膜癌的保守治疗：初步研究。
Int J Gynecol Cancer. 2011 May;21(4):673-7. doi: 10.1111/IGC.0b013e3181fd9a06.
10
Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006).左炔诺孕酮宫内缓释系统治疗子宫内膜增生的管理：单臂、前瞻性多中心研究：韩国妇科肿瘤学组研究（KGOG2006）。
Jpn J Clin Oncol. 2011 Jun;41(6):817-9. doi: 10.1093/jjco/hyr048. Epub 2011 Apr 7.

左炔诺孕酮宫内缓释系统在妇科疾病中的临床应用。

Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.

作者信息

Kim Mi-La, Seong Seok Ju

机构信息

Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea.

出版信息

Obstet Gynecol Sci. 2013 Mar;56(2):67-75. doi: 10.5468/OGS.2013.56.2.67. Epub 2013 Mar 12.

DOI:10.5468/OGS.2013.56.2.67
PMID:24327984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3784091/
Abstract

The levonorgestrel-releasing intrauterine system (LNG-IUS), originally designed for contraception, has since been applied to various gynecologic diseases. This article summarizes the current status of clinical applications of LNG-IUS to the treatment of gynecologic diseases such as heavy menstrual bleeding, endometriosis, leiomyoma, adenomyosis, endometrial hyperplasia, and early-stage endometrial cancer.

摘要

左炔诺孕酮宫内节育系统（LNG-IUS）最初设计用于避孕，此后已应用于各种妇科疾病。本文总结了LNG-IUS在治疗月经过多、子宫内膜异位症、子宫肌瘤、子宫腺肌病、子宫内膜增生和早期子宫内膜癌等妇科疾病方面的临床应用现状。